the prostaglandins studied were 15-methyl pgf2 alpha methyl ester ( 0.5 and 1.0 mg ) , 16,16-dimethyl-trans-delta 2 pge1 methyl ester ( 1.0 mg ) , 9-deoxo-16,16-dimethyl-9-methylene pge2 ( 30 mg ) , all administered by the vaginal route , and 16-phenoxy-omega-17,18 , 19,20-tetranor pge2 methyl sulfonylamide ( 0.25 and 0.5 mg ) given as i.m . injections .
C0033554
prostaglandins
C0012472
pge2